期刊文献+

糖基化终末产物与血管疾病 被引量:11

下载PDF
导出
摘要 糖基化终末产物是体内蛋白质与葡萄糖或其他还原单糖反应生成的稳定的共价化合物 ,它可通过损伤血管内皮、促进白细胞粘附、增加血小板聚集和刺激血管平滑肌增殖等机制 ,促进动脉粥样硬化、糖尿病血管并发症、尿毒症以及血管性勃起功能障碍等疾病的发生发展。因此 ,寻找或开发抑制糖基化终末产物形成和作用的抑制药对预防和治疗血管疾病有着重要的意义。
出处 《国外医学(生理病理科学与临床分册)》 2004年第4期360-362,共3页 Foreign Medical Sciences(Pathophysiology and Clinical Medicine)
  • 相关文献

参考文献19

  • 1Peppa M, Uribarri J, Vlassara H. The role of advanced glycation end products in the development of atherosclerosis [ J ]. Curt Diab Rep, 2004, 4( 1 ) :31-36.
  • 2Panagiotopoulos S, OBrien RC, Bucala R, et al. Aminoguanidine has an anti -atherogenic effect in the cholesterol-fed rabbit[ J]. Atherosclerosis, 1998, 136( 1 ) :125-131.
  • 3Kanauchi M, Tsujimoto N, Hashimoto T. Advanced glycation end products in nondiabetic patients with coronary artery dinsease [ J ].Diabetes Care, 2001, 24 ( 9 ) : 1620-1623.
  • 4Lin RY, Choudhury RP, Cai W, et al. Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice[ J]. Atherosclerosis, 2003, 168(2): 213-220.
  • 5Forbes JM, Thallas V, Thomas MC, et al. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes [ J ]. FASEB J, 2003, 17(12) : 1762-1764.
  • 6Gardiner TA, Anderson HR, Stitt AW. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes [ J ]. J Pathol, 2003,201(2): 328-33.
  • 7Heidland A, Sebekova K, Schinzel R. Advanced glycation end products and the progressive course of renal disease[ J]. Am J Kidney Dis, 2001, 38(4 Suppl 1): S100-106.
  • 8Friedlander MA, Witko-Sarsat V, Nguyen AT, et al. The advanced glycation endproduct pentosidine and monocyte activation in uremia[J]. Clin Nephrol, 1996, 45(6) : 379-382.
  • 9Miyata T, Saito A, Kurokawa K, et al. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity[ J]. Nephrol Dial Transplant, 2001,16 ( Suppl 4) :8-11.
  • 10Cartledge JJ, Eardley I, Morrison JF. Advanced glycation endproducts are responsible for the impairment of corpus cavemosal smooth muscle relaxation seen in diabetes[J]. BJU Int, 2001, 87(4) :402-407.

同被引文献137

引证文献11

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部